Bases moleculares y celulares de enfermedades inflamatorias/autoinmunes
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (10)
2021
-
Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
Clinical and Experimental Rheumatology, Vol. 39, Núm. 3, pp. 555-563
2020
-
Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
Lupus, Vol. 29, Núm. 12, pp. 1556-1565
-
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies
Autoimmunity Reviews, Vol. 19, Núm. 1
2017
-
Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus
Seminars in Arthritis and Rheumatism, Vol. 47, Núm. 1, pp. 38-45
2016
2015
2014
-
Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: Case-control study
Arthritis Research and Therapy, Vol. 16, Núm. 1
2009
-
Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-κB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility
Arthritis Research and Therapy, Vol. 11, Núm. 2
-
Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, Eotaxin-3, and MHC2TA
Journal of Rheumatology, Vol. 36, Núm. 8, pp. 1590-1595
-
Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors
Arthritis and Rheumatism, Vol. 60, Núm. 9, pp. 2558-2564